Femasys (FEMY) Shares Outstanding (Diluted Average) (2020 - 2025)
Femasys (FEMY) reported Shares Outstanding (Diluted Average) of $39.5 million for Q4 2025, up 77.61% on a YoY basis from $22.3 million in Q4 2024, and up 46.34% quarter-over-quarter from $27.0 million in Q2 2025.
Femasys (FEMY) Shares Outstanding (Diluted Average) (2020 - 2025) Analysis & Trends
Femasys has reported Shares Outstanding (Diluted Average) for 6 years, with the latest figure at $39.5 million in Q4 2025.
- For the quarter ending Q4 2025, Shares Outstanding (Diluted Average) rose 77.61% year-over-year to $39.5 million; the trailing twelve-month figure through Dec 2025 stood at $39.5 million (up 77.61% YoY), and the FY2025 full-year result was $39.5 million, up 77.61% from the prior year.
- Shares Outstanding (Diluted Average) for Q4 2025 stood at $39.5 million, up from $27.0 million in the prior quarter.
- The five-year high for Shares Outstanding (Diluted Average) was $39.5 million in Q4 2025, with the low at $995208.0 in Q1 2021.
- Historically, Shares Outstanding (Diluted Average) has averaged $15.6 million across 5 years, with a median of $13.1 million in 2023.
- Annual changes were most pronounced in 2022 — Shares Outstanding (Diluted Average) jumped 1086.1% — and 2023, when it rose 0.58%.
- Femasys' Shares Outstanding (Diluted Average) stood at $6.7 million in 2021, then soared by 76.03% to $11.8 million in 2022, then surged by 30.21% to $15.4 million in 2023, then surged by 44.74% to $22.3 million in 2024, then soared by 77.61% to $39.5 million in 2025.
- The last three Shares Outstanding (Diluted Average) figures came in at $39.5 million (Q4 2025), $27.0 million (Q2 2025), and $25.1 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 359.80 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 824.84 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 145.72 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 72.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 175.50 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 195.00 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 71.61 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 515.00 Mn |
| 10 | Femasys | 254.59 Mn | 249.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 39.55 Mn |
| Jun 30, 2025 | 27.03 Mn |
| Mar 31, 2025 | 25.15 Mn |
| Dec 31, 2024 | 22.27 Mn |
| Sep 30, 2024 | 22.23 Mn |
| Jun 30, 2024 | 22.00 Mn |
| Mar 31, 2024 | 21.78 Mn |
| Dec 31, 2023 | 15.38 Mn |
| Sep 30, 2023 | 15.09 Mn |
| Jun 30, 2023 | 13.11 Mn |
| Mar 31, 2023 | 11.87 Mn |
| Dec 31, 2022 | 11.82 Mn |
| Sep 30, 2022 | 11.81 Mn |
| Jun 30, 2022 | 11.81 Mn |
| Mar 31, 2022 | 11.80 Mn |
| Dec 31, 2021 | 6.71 Mn |
| Sep 30, 2021 | 5.00 Mn |
| Jun 30, 2021 | 1.54 Mn |
| Mar 31, 2021 | 995,208.00 |
| Dec 31, 2020 | 959,862.00 |